25 Percent Dextrose Injection, USP (Infant) by Hospira: Recall - Particulate Matter
Date of publication: 24-04-2017
Particulate administered to a patient could result in local swelling, irritation of blood vessels or tissue, blockage of blood vessels and/or systemic allergic response to the particulate. Źródło: https://www.fda.gov
